We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNK icon
76
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.07B
$120M 0.26%
1,073,016
+84,704
+9% +$9.42M
DIS icon
77
Walt Disney
DIS
$167B
$117M 0.25%
1,103,093
-17,752
-2% -$1.94M
PPL
78
PPL Corp
PPL
$26.8B
$117M 0.25%
3,031,541
+232,246
+8% +$8.98M
LMT icon
79
Lockheed Martin
LMT
$132B
$116M 0.25%
418,297
+16,463
+4% +$4.52M
CME icon
80
CME Group
CME
$96.1B
$114M 0.25%
913,556
+100,968
+12% +$12.1M
TWX
81
DELISTED
Time Warner Inc
TWX
$114M 0.25%
1,137,299
-171,809
-13% -$17M
CCI icon
82
Crown Castle
CCI
$33.4B
$114M 0.25%
1,138,949
-39,713
-3% -$3.9M
MMM icon
83
3M
MMM
$90.8B
$114M 0.25%
655,328
+8,786
+1% +$1.47M
ABT icon
84
Abbott
ABT
$183B
$111M 0.24%
2,291,070
+226,590
+11% +$10.3M
EFA icon
85
iShares MSCI EAFE ETF
EFA
$78.5B
$110M 0.24%
1,680,015
+11,093
+0.7% +$718K
TEL icon
86
TE Connectivity
TEL
$59.9B
$109M 0.24%
1,384,454
-43,489
-3% -$3.33M
MCHP icon
87
Microchip Technology
MCHP
$40.7B
$107M 0.23%
2,776,774
-263,362
-9% -$10.4M
BABA icon
88
Alibaba
BABA
$279B
$107M 0.23%
759,284
+121,556
+19% +$15M
BP icon
89
BP
BP
$114B
$106M 0.23%
3,458,295
+37,888
+1% +$1.18M
FLRN icon
90
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.08B
$106M 0.23%
3,438,682
+371,174
+12% +$11.4M
AMGN icon
91
Amgen
AMGN
$209B
$105M 0.23%
611,573
+27,758
+5% +$4.51M
APD icon
92
Air Products & Chemicals
APD
$66.8B
$104M 0.23%
727,528
+107,585
+17% +$15.3M
SPIB icon
93
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$104M 0.22%
3,017,651
+320,550
+12% +$11M
USB icon
94
US Bancorp
USB
$98B
$101M 0.22%
1,941,652
+63,262
+3% +$3.26M
BA icon
95
Boeing
BA
$175B
$100M 0.22%
507,251
-1,989
-0.4% -$370K
MDT icon
96
Medtronic
MDT
$110B
$99.1M 0.21%
1,116,088
-31,525
-3% -$2.66M
PNC icon
97
PNC Financial Services
PNC
$99.2B
$98.9M 0.21%
791,864
+25,943
+3% +$3.13M
BND icon
98
Vanguard Total Bond Market
BND
$158B
$97.9M 0.21%
1,196,302
+87,384
+8% +$7.14M
GIS icon
99
General Mills
GIS
$19.4B
$95.3M 0.21%
1,720,757
+455,354
+36% +$26M
SO icon
100
Southern Company
SO
$106B
$95.1M 0.21%
1,987,142
-673,227
-25% -$33.8M

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.